Trials / Completed
CompletedNCT04930952
Complications of Ethanol-amine Oleate Intralesional Sclerotherapy
Complications of Ethanol-amine Oleate Intralesional Sclerotherapy Injections of Maxillofacial Venous Malformations in Pediatric Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Suez Canal University · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- —
Summary
The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations in pediatric patients
Detailed description
Maxillofacial Venous malformations cause many functional and esthetic complications in children, intralesional sclerotherapy is the best choice of treatment; and Ethanol-amine Oleate has been the most commonly used sclerosing agent. The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ethanol-amine Oleate Sclerotherapy Injection | Intralesional Sclerotherapy Injection |
Timeline
- Start date
- 2019-02-28
- Primary completion
- 2021-02-28
- Completion
- 2021-03-03
- First posted
- 2021-06-18
- Last updated
- 2021-06-18
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04930952. Inclusion in this directory is not an endorsement.